Oakview Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-273,706
| Closed | -$9.92M | – | 17 |
|
|
2021
Q1 | $9.92M | Sell |
273,706
-5,196
| -2% | -$188K | 3.61% | 16 |
|
|
2020
Q4 | $10.3M | Sell |
278,902
-125,033
| -31% | -$4.6M | 4.34% | 14 |
|
|
2020
Q3 | $14.1M | Sell |
403,935
-709
| -0.2% | -$24.7K | 6.14% | 10 |
|
|
2020
Q2 | $12.6M | Sell |
404,644
-319,615
| -44% | -$9.92M | 5.76% | 9 |
|
|
2020
Q1 | $22.4M | Buy |
724,259
+97,527
| +16% | +$3.02M | 9.86% | 1 |
|
|
2019
Q4 | $23.3M | Buy |
626,732
+61,774
| +11% | +$2.3M | 8.58% | 2 |
|
|
2019
Q3 | $19.3M | Sell |
564,958
-14,137
| -2% | -$482K | 6.59% | 8 |
|
|
2019
Q2 | $23.8M | Sell |
579,095
-17,626
| -3% | -$724K | 7.84% | 5 |
|
|
2019
Q1 | $24M | Buy |
596,721
+226,390
| +61% | +$9.12M | 7.62% | 5 |
|
|
2018
Q4 | $15.3M | Sell |
370,331
-252,882
| -41% | -$10.5M | 5.69% | 11 |
|
|
2018
Q3 | $26.1M | Sell |
623,213
-145,982
| -19% | -$6.1M | 9.32% | 2 |
|
|
2018
Q2 | $26.5M | Sell |
769,195
-84,468
| -10% | -$2.91M | 10.59% | 1 |
|
|
2018
Q1 | $28.7M | Buy |
853,663
+60,517
| +8% | +$2.04M | 11.51% | 1 |
|
|
2017
Q4 | $27.3M | Buy |
793,146
+91,048
| +13% | +$3.13M | 12.13% | 1 |
|
|
2017
Q3 | $23.8M | Buy |
+702,098
| New | +$23.8M | 11.33% | 3 |
|
|
2017
Q2 | – | Sell |
-642,195
| Closed | -$20.8M | – | 26 |
|
|
2017
Q1 | $20.8M | Buy |
642,195
+57,847
| +10% | +$1.88M | 9.9% | 2 |
|
|
2016
Q4 | $18M | Buy |
+584,348
| New | +$18M | 10.16% | 1 |
|